Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,826 | 18,688 | 13,487 | 9,862 | 12,340 |
| Marketable Securities | 22,872 | 100 | 100 | 1,950 | 2,452 |
| Receivables | N/A | N/A | N/A | N/A | 146 |
| Other current assets | 0 | 0 | 0 | 19 | 28 |
| TOTAL | $33,429 | $19,295 | $13,775 | $12,163 | $15,672 |
| Non-Current Assets | |||||
| PPE Net | 78 | 65 | 52 | 95 | 124 |
| Other Non-Current Assets | 26 | 196 | 1,092 | 1,432 | 421 |
| TOTAL | $104 | $261 | $1,144 | $1,526 | $544 |
| Total Assets | $33,533 | $19,557 | $14,919 | $13,690 | $16,216 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,459 | 934 | 852 | 1,185 | 1,821 |
| TOTAL | $2,459 | $934 | $852 | $1,185 | $1,821 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,893 | 5,164 | 2,908 | 973 | 3,100 |
| TOTAL | $4,493 | $5,997 | $4,534 | $1,798 | $4,000 |
| Total Liabilities | $6,953 | $6,931 | $5,385 | $2,984 | $5,821 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 373 | 368 | 249 | 199 | 181 |
| Common Shares | 18 | 15 | 12 | 10 | 8 |
| Retained earnings | -91,332 | -72,811 | -63,311 | -57,085 | -45,740 |
| Other shareholders' equity | -162 | -28 | -28 | -28 | -31 |
| TOTAL | $26,581 | $12,626 | $9,534 | $10,706 | $10,396 |
| Total Liabilities And Equity | $33,533 | $19,557 | $14,919 | $13,690 | $16,216 |